ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Register for Details

For more details on financing and valuation for ADC Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is ADC Therapeutics's ticker symbol?


What is ADC Therapeutics's stock price?

0.91 as of 9/26/23

Learn more about ADC Therapeutics

Forge green plus iconForge green minus icon

What is ADC Therapeutics funding to date?

ADC Therapeutics has raised $200.02MM to date.
Updated on: Jun 12, 2022